Skip to Content
Contact Form Map & Directions Videos

Search Results: avandia

Multi-Billion Dollar Settlements for Big Pharma

01/8/2014
Articles
BY

Three years ago, Public Citizen issued a report that documents all of the settlements between pharmaceutical giants and the federal and state governments due to violations such as overcharging patients or by off-label marketing. At the time the tally was about $20 billion covering a period of 20 years. The […]

Read More

New Diabetes Drugs Still Present Risks

09/23/2013
Articles
BY

The search has been on for a new and improved drug treatment for type 2 diabetes that would leave the complications of Avandia in the past. That hasn’t happened. New Class of Diabetes Drugs, DPP-4 The latest findings concern a newer class of diabetes drugs called DPP-4 that lower blood […]

Read More

FDA Adds Authority over Clinical Trials

10/10/2012
Articles
BY

Where, oh where does clinical trial data go? Earlier this year, the British Medical Journal (BMJ) wrote that a large proportion of evidence from human clinical trials goes missing while cherry-picked favorable data appears. According to the BMJ, fewer than half of the data from clinical trials run using National […]

Read More

Dangerous Top Ten Drugs

04/27/2012
Articles
BY

The Top Ten of anything usually designates the ‘best’ but not in this case. An online report from Adverse Events Inc., an independent company that analyzes the FDA’s database of Adverse Event Reporting System (AERS), has just issued its Top Ten list of Dangerous Drugs for the second quarter Q2 […]

Read More

Actos Litigation Over Bladder Cancer

03/7/2012
Actos
BY

A recently unsealed complaint filed by whistleblower Helen Ge reveals that over four years, Takeda Pharmaceuticals failed to report to the FDA congestive heart failure cases in patients taking Actos. Takeda manufactures the Type II diabetes drug Actos. Actos is the third in a long line of failed Type II […]

Read More

GlaxoSmithKline fined $3 Billion

07/5/2012
Blog
BY

The United States Justice Department has fined British drug company GlaxoSmithKline $3 billion for failing to accurately report safety data related to two of its most popular drugs, Wellbutrin and Paxil.  The fine is divided – $2 billion to resolve the largest fraud settlement in U.S. history and $1 billion […]

Read More

Hear What Our Clients Have To Say

"Nick DeBellis obtained the maximum recovery of full insurance limits in the case we worked on. He is a true professional and recommend him to anyone in South Florida."
Posted By: Michael Geoffroy